All News Top News Apr 23, 2019 Teva Announces Update on Fremanezumab Clinical Development for use in Episodic Cluster Headache Learn More Share Top News Apr 22, 2019 Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States Learn More Share Top News Apr 11, 2019 Teva Announces Launch of a Generic Version of AndroGel® (testosterone gel) 1.62% CIII in the United States Learn More Share Top News Apr 10, 2019 Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility Learn More Share Top News Apr 8, 2019 Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019 Learn More Share
Top News Apr 23, 2019 Teva Announces Update on Fremanezumab Clinical Development for use in Episodic Cluster Headache Learn More
Top News Apr 22, 2019 Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States Learn More
Top News Apr 11, 2019 Teva Announces Launch of a Generic Version of AndroGel® (testosterone gel) 1.62% CIII in the United States Learn More
Top News Apr 8, 2019 Teva to Host Conference Call to Discuss First Quarter 2019 Financial Results at 8 a.m. ET on May 2, 2019 Learn More